Sort
53,477 grants matching “addiction”
Communicating Smoking Risks Through Graphic Warning Labels
$491,627Daniel Romer · University Of Pennsylvania · R01 · FY2013 · CA
Application of Physiologically-Based Pharmacokinetic Modeling to Characterize Drug-Drug Interactions in Infants
$491,626Daniel Gonzalez · Univ Of North Carolina Chapel Hill · R01 · FY2022 · HD
Research Project 3 : Nicotine Delivery Rate and Its Abuse Potential: Impact of Menthol
$491,619Mehmet Sofuoglu · Yale University · U54 · FY2018 · DA
Licit & Illicit Opioids: Comparative Studies in Humans
$491,594Sharon L. Walsh · University Of Kentucky · R01 · FY2007 · DA
Adrenergic Pharmacotherapies for d-MA Depependence
$491,567California Pacific Med Ctr Res Institute · P50 · FY2004 · DA
Building Cultures of Recovery in Tribal Communities
$491,531Martina Whelshula · Healing Lodge Of The Seven Nations · S06 · FY2018 · GM
Targeted Inhibition in Leukemia
$491,521Nicolas Nassar · Cincinnati Childrens Hosp Med Ctr · R01 · FY2023 · CA
Targeted Inhibition in Leukemia
$491,521Nicolas Nassar · Cincinnati Childrens Hosp Med Ctr · R01 · FY2022 · CA
Yale Drug Abuse, Addiction, and HIV Research Scholars (Yale-DAHRS)
$491,490Gail D'onofrio · Yale University · K12 · FY2015 · DA
Stop-and-Frisk, Arrest, and Incarceration and STI/HIV Risk in Minority MSM
$491,469Maria Rabia Khan · New York University School Of Medicine · R01 · FY2021 · DA
Knowledge-guided automated machine learning methods for modeling the interaction of HIV with addictive drugs
$491,450Jason H. Moore · Cedars-Sinai Medical Center · R01 · FY2025 · LM
Identification of small molecule that selectively modulate Ghrelin receptor (GHSR1a) b-arrestin signaling as a new therapeutic approach for the treatment of addiction
$491,448Juan Marugan · National Center For Advancing Translational Sciences · ZIA · FY2024 · TR
Spinal Manipulation and Patient Self-Management for Preventing Acute to Chronic Back Pain (PACBACK) Study
$491,416Gert Bronfort · University Of Minnesota · UH3 · FY2023 · AT
Translational Training in Addiction
$491,399Melissa Jean Zielinski · Univ Of Arkansas For Med Scis · T32 · FY2024 · DA
Endogenous Opioid Dysfunction, Stress, and Risk for Smoking Relapse
$491,383Mustafa N Al'absi · University Of Minnesota · R01 · FY2020 · DA
Emergence of valence coding in the ventral striatum
$491,361Venkatesh N Murthy · Harvard University · R01 · FY2023 · DC
Emergence of valence coding in the ventral striatum
$491,361Venkatesh N Murthy · Harvard University · R01 · FY2022 · DC
Emergence of valence coding in the ventral striatum
$491,361Venkatesh N Murthy · Harvard University · R01 · FY2021 · DC
Emergence of valence coding in the ventral striatum
$491,361Venkatesh N Murthy · Harvard University · R01 · FY2020 · DC
Intensive Outpatient v. Outpatient Treatment with Buprenorphine among African Ame
$491,343Shannon Gwin Mitchell · Friends Research Institute, Inc. · RC1 · FY2010 · DA
Enhanced Treatment Management of Opioid-Dependence in an Office-Based Setting
$491,331Anand Mattai · Medicasafe, Inc. · R44 · FY2018 · DA
Novel selective alpha4beta2 nicotinic receptor antagonists for smoking cessation
$491,318Jinhua Wu · Assuage Pharmaceuticals, Inc. · R44 · FY2015 · DA
Understanding how opioids affect the experiential and neural signatures of feelings of social connection with close others
$491,317Tristen K. Inagaki · San Diego State University · R01 · FY2022 · DA
PDZ Domains and AMPA Receptor Function
$491,260Richard L Huganir · Johns Hopkins University · R01 · FY2019 · NS
IDENTIFYING EPIGENOMICS AND CONNECTOMICS OF PROTRACTED OPIOID WITHDRAWAL AND RELAPSE USING CELLULAR BARCODING
$491,250Justus M Kebschull · Johns Hopkins University · DP1 · FY2024 · DA